This inventor holds 1 USPTO granted patent. Top assignees: Academy of Military Medical Sciences, Chengdu Aupone Pharmaceutical Co., Ltd, Sichuan University. Active years: 2026.
Company Filing History:
1 out of 14 
1 out of 1 
1 out of 260 Years Active: 2026
Title: The Innovative Contributions of Ruijie Zhou
Introduction
Ruijie Zhou is a notable inventor based in Chengdu, China. He has made significant contributions to the field of chemistry, particularly in the synthesis of C-nucleoside compounds. His work is characterized by innovative methods that enhance production efficiency and reduce costs.
Latest Patents
One of Ruijie Zhou's key patents is titled "Method for synthesizing C-nucleoside compound." This patent discloses a method for preparing a C-nucleoside compound represented by Formula (III) or its salt. The method boasts a high reaction yield and is simple to operate. It utilizes a single metal reagent and maintains stable reaction temperature conditions. Additionally, it does not require frequent changes to the reaction system during the operation process, making it suitable for scale-up synthesis and large-scale production of Remdesivir. The method is also cost-effective, which is a significant advantage in pharmaceutical manufacturing.
Career Highlights
Ruijie Zhou has worked at prestigious institutions such as Sichuan University and the Academy of Military Medical Sciences. His experience in these organizations has allowed him to develop and refine his innovative methods in chemical synthesis.
Collaborations
Throughout his career, Ruijie Zhou has collaborated with notable colleagues, including Yong Qin and Wu Zhong. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Ruijie Zhou's contributions to the field of chemistry, particularly through his innovative patent for synthesizing C-nucleoside compounds, highlight his role as a significant inventor. His work not only enhances production efficiency but also supports the large-scale manufacturing of essential pharmaceuticals.